Skip to main content

Mitrano Richard J.'s Form 4/A amendment

Amended

Korro Bio, Inc. (KRRO) · filed Jul 12, 2023

Accession no.
0000950170-23-032732
Filed
Jul 12, 2023, 9:18 PM ET
Trade date
Jul 4-6, 2023
Filing delay
8 days
Rule 10b5-1 plan
Checked
Original filed
Jul 7, 2023

This filing lists 2 non-derivative transactions and 1 derivative transaction. It carries over 4 transactions from the original filing that it did not restate. Open-market sales total $78.4. It was filed 8 days after the trade.

This amendment restates part of 0001127602-23-020481 (filed Jul 7, 2023). The transactions it did not restate still count and are listed below.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mitrano Richard J.CIK 0001785287Officer (VP Finance & Operations)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 4, 2023Common StockMOption exerciseAcquired+25,000–F1–55,995Direct
Jul 6, 2023Common StockSSaleDisposed−224$0.35−$78.455,771Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 4, 2023Common StockMOption exerciseDisposed−25,000–F1–0Direct

Carried over from the original filing

This amendment restates only part of the original filing. The original's other transactions still stand, and the trade tables on Livermore count them under this amendment.

From 0001127602-23-020481 (filed Jul 7, 2023).

Non-derivative securities (Table I)

Non-derivative transactions carried over from 0001127602-23-020481
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jul 5, 2023Common StockMOption exerciseAcquired+758–F1–31,753Direct
Jul 6, 2023Common StockMOption exerciseAcquired+758–F1–32,287Direct

Derivative securities (Table II)

Derivative transactions carried over from 0001127602-23-020481
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jul 5, 2023Common StockMOption exerciseDisposed−758–F1–24,242Direct
Jul 6, 2023Common StockMOption exerciseDisposed−758–F1–23,484Direct

Footnotes on the original

The footnotes that the prices of these transactions refer to on the original filing.

F1

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Referenced by the price of 2 transactions in Table I and 2 transactions in Table II.

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.

Referenced by the price of 1 transaction in Table I and 1 transaction in Table II.

F2

Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the restricted stock units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.

F3

The Restricted Stock Units vested on July 4, 2023 and do not have an expiration date.

Remarks

This Form 4/A is being filed to correct (i) the vesting transaction dates, (ii) the number of Restricted Stock Units reported as vesting on Table II in columns 5 and 7, (iii) the aggregate derivatives following the transaction on Table II in column 9, (iv) the acquisition of shares on Table I in column 4, and (v) the aggregate securities following the transaction in column 5 of Table I.

Read the full filing on SEC EDGAR (opens in a new tab)